Total | Heart failure | |||
---|---|---|---|---|
YES | NO | p | ||
Demographic data | ||||
Age (years) | 62.8 ± 13.3 | 67.4 ± 11.6 | 62.6 ± 13.4 | 0.244 |
Female, % | 24.7 | 27.3 | 35.0 | 0.841 |
Medical history | ||||
BMI (Kg/m2) | 27.0±3.3 | 25.7±3.9 | 27.1±3.5 | 0.225 |
Current smoking, % | 34.5 | 27.3 | 35.0 | 0.703 |
Diabetes, % | 26.8 | 36.4 | 26.2 | 0.461 |
Hypertension, % | 47.9 | 63.6 | 47.0 | 0.283 |
Dyslipidemia, % | 44.8 | 45.5 | 44.7 | 0.957 |
On admission data | ||||
STEMI, % | 52.1 | 72.7 | 50.8 | 0.158 |
Killip class ≥ II, % | 13.9 | 36.4 | 12.6 | 0.027 |
Systolic blood pressure (mmHg) | 137.0 ± 26.4 | 135.8 ± 25.7 | 137.1 ± 26.5 | 0.881 |
Heart rate (bpm) | 75.2 ± 18.8 | 93.8 ± 16.4 | 74.1 ± 18.4 | 0.001 |
Atrial fibrillation, % | 8.2 | 18.2 | 7.7 | 0.217 |
Haemoglobin (g/dL) | 14.3 ± 1.6 | 13.1 ± 1.5 | 14.4 ± 1.6 | 0.011 |
Leukocytes (103/μL) | 9.8 ± 4.0 | 9.6 ± 4.1 | 10.9 ± 4.0 | 0.314 |
Creatinine (mg/dL) | 0.95 ± 0.15 | 0.99 ± 0.12 | 0.95 ± 0.16 | 0.396 |
Laboratory parameters | ||||
TPI peak (ng/dL) | 17.1 (5.6-68.2) | 114.7 (23.5-171.5) | 15.3 (5.2-59.4) | 0.024 |
NT-proBNP (pg/mL) | 801.5 (352.7-1779.3) | 2938.0 (1400.0-3655.0) | 769.5 (320.5-1663.2) | 0.011 |
Glycation products | ||||
Glucose (mg/dL) | 152.9 ± 74.1 | 203.0± 96.7 | 149.9 ± 71.7 | 0.021 |
Fructosamine (mg/dL) | 192.4 ± 71.5 | 243.5 ± 95.3 | 188.5 ± 68.2 | 0.019 |
HbA1c (%) | 6.2 ± 1.4 | 7.1 ± 2.3 | 6.1 ± 1.3 | 0.017 |
AGE fluorescent (AU) | 57.3 ± 45.0 | 95.9 ± 83.1 | 54.9 ± 40.9 | 0.003 |
Procedural characteristics | ||||
LVEF ≤ 45%, % | 19.6 | 54.5 | 17.5 | 0.003 |
Multivessel disease, % | 52.1 | 63.6 | 51.4 | 0.429 |
PCI, % | 82.0 | 72.7 | 82.5 | 0.412 |
CABG, % | 5.7 | 9.1 | 5.5 | 0.617 |
Complete revascularization, % | 80.2 | 37.5 | 82.3 | 0.002 |
Medical treatment | ||||
Acetylsalicylic acid | 100.0 | 100.0 | 100.0 | - |
Clopidogrel | 99.0 | 98.9 | 100.0 | 0.722 |
Anti-IIb-IIIA | 19.1 | 9.1 | 19.7 | 0.386 |
B-blockers | 86.1 | 90.8 | 85.8 | 0.634 |
ACE Inhibitors-ARAII | 89.7 | 89.6 | 90.9 | 0.767 |
Anti-aldosterone medication | 20.1 | 63.6 | 17.5 | <0.001 |
Statins | 94.9 | 90.0 | 95.2 | 0.463 |
Insulin | 5.7 | 18.2 | 4.9 | 0.065 |
Oral anti-diabetics | 11.8 | 20.0 | 11.3 | 0.408 |